STAT+: Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye treatment
A Turkish court overturned a decision by the national antitrust regulator that two years ago…
Author: STAT
STAT+: Pharmalittle: ALS Association and its chapters battle over money and priorities; eye drops recalled over links to drug-resistant infections
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Public health layoffs and tech layoffs: a world of difference
Layoffs in the tech sector — think Google, Amazon, Meta, and the like — from…
STAT+: They were the 10% left out of life-changing treatments. Now these cystic fibrosis patients may finally get help
Vertex Pharmaceuticals revolutionized the treatment of cystic fibrosis. It also has unfinished business. The Boston…
Opinion: The FDA is the right agency to regulate CBD products, but it needs help
The dietary supplement industry has been begging for federal oversight of products containing cannabidiol (CBD),…
The FTC is finally ready take on health data leaks. The problem is bigger than GoodRx
The Federal Trade Commission took aim at prescription drug coupon site GoodRx this week in…
STAT+: Leading ALS advocacy group roiled by infighting over money and priorities
A blistering battle has broken out between the ALS Association and more than a dozen…
STAT+: Teva quits brand lobby PhRMA, in line to lead generic lobby AAM
WASHINGTON — Teva Pharmaceuticals has quit the Pharmaceutical Research and Manufacturers of America, STAT has…
FTC goes after GoodRx, the controversy around lifesaving devices, and Verily’s future research
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Rare polio case highlights how hard it will be to keep polio gone once it’s eradicated
An incident that took place at a Dutch polio vaccine production facility late last year…
STAT+: From industry ‘greed’ to workforce shortages, Sanders and Cassidy lay out health committee agenda
The Senate finally made long-expected committee assignments official on Thursday, kickstarting a new session for…
Listen: Pharma blockbusters, pandemic policy, & legal chicanery
Is the next Lipitor on the way? When is a pandemic over-over? And what’s a…
Eye drops linked to U.S. drug-resistant bacteria outbreak
NEW YORK — U.S. health officials are advising people to stop using over-the-counter eye drops…
A majority of Americans support banning all tobacco products: Survey
WASHINGTON – A majority of Americans support banning all tobacco products, according to a new…
STAT+: Pharmalittle: GSK CEO warns U.K. pharma industry is at a ‘tipping point’; Gavi tussles with vaccine makers over refunds
Top of the morning to you. And a fine one it is. Sunny skies and…
Venture capital is investing little in new treatment for addiction, report finds
There are about as many Americans living with addiction as there are Americans living with…
Opinion: Generics: a missing piece in China’s Covid-19 crisis response
China’s massive Covid-19 crisis, sparked in part by the country’s rolling back its strict zero-Covid…
Opinion: Invasive strep A: bad in affluent countries, far worse in low-income nations
The deaths of nearly 30 children under the age of 15 years from invasive strep…
STAT+: New York’s hospitals are poised for political power this Congress
WASHINGTON — The new Democratic leadership team in Congress is pretty much the New York…
These blood-clot catching devices have been controversial for years. Why are doctors still relying on them?
Inferior vena cava filters are supposed to save lives. The spider-like devices catch blood clots…
STAT+: Biden administration floats major 2024 pay cut for Medicare Advantage plans
Medicare Advantage insurers could face an average 2.3% cut to baseline payments in 2024, the…
STAT+: FTC Commissioner criticizes $1.5 million GoodRx fine for health data leaks
On Wednesday, the Federal Trade Commission made history by enforcing, for the first time, its…
GoodRx leaked sensitive health information to Facebook and Google, FTC alleges
The Federal Trade Commission on Wednesday accused GoodRx, the prescription drug discount platform, of sharing…
Opinion: Disruptive science is leaping forward, not limping along
A recent study and accompanying news story in the preeminent journal Nature provocatively concludes that…
STAT+: New antidepressant study provides hints to Verily’s future
A small Phase 2 trial of a new antidepressant may hold clues to the direction…
STAT+: Pharmalittle: Pfizer projects lower revenue from Covid-19 products; Medicare eyes policy for paying less for accelerated-approval drugs
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Medicare Advantage insurers will score $2 billion gift thanks to limited audits
Medicare officials made a clear statement four years ago about how best to audit the…
STAT+: KKR veteran sets records with $3.9 billion health care fund
The former head of health care investing at private equity giant KKR has set records…
Opinion: Unlocking the promise of learning from everyone with cancer
Locked behind the firewalls of proprietary systems sits a treasure trove of data that could…
Opinion: Promises — and pitfalls — of ChatGPT-assisted medicine
Not long after the artificial intelligence company OpenAI released its ChatGPT chatbot, the application went…
STAT+: 6 things to know about Apellis’ eye drug ahead of FDA decision
The Food and Drug Administration is nearing a decision on the first treatment for geographic…
MRI scans reveal disparate impact of poverty and other ‘toxic stress’ on brains of Black children
Stressful experiences during early childhood — particularly economic strife — appear to act as a…
STAT+: Medicare may test policy of paying less for accelerated approval drugs
A Medicare official hinted Tuesday that Medicare might test a policy of paying less for…
STAT+: Pharmalittle: Amgen pricing for Humira biosimilar may not help patients; pharma wins court battle over drug discount program
Hello, everyone, and how are you this morning? We are just fine, thank you, although…
STAT+: Amgen pricing for its Humira biosimilar may benefit PBMs and insurers more than patients
Underscoring the opaque and confusing nature of pharmaceutical pricing, Amgen announced long-awaited pricing for its…
Opinion: How the Biden administration’s Covid preparedness policies could narrow America’s political divide
The White House’s Covid Winter Preparedness Plan is a missed opportunity to narrow the divide…
Town Hall Ventures’ Andy Slavitt on how to invest in Medicaid and health tech
SAN FRANCISCO — Part of Andy Slavitt’s core mission at Town Hall Ventures is proving…
Opinion: A watershed year for biosimilars — if regulators and policymakers step up
January 31 is set to mark the start of a watershed year for the biosimilars…
STAT+: Alphabet’s laid-off health tech employees on where their work heads next
Big Tech has gone through a rough stretch of layoffs — between Meta, Amazon, Alphabet,…
STAT+: FDA may not always require post-approval trials to be enrolled before accelerated approvals
WASHINGTON — A Food and Drug Administration official on Monday gave more clues for how…
President Biden to end Covid-19 emergencies on May 11
WASHINGTON — President Joe Biden informed Congress on Monday that he will end the twin…
STAT+: Medicare Advantage insurers to repay billions under final federal audit rule
The federal government will audit Medicare Advantage insurers aggressively under a rule finalized Monday, which…
STAT+: Gene therapy can transform life for people with hemophilia. But some patients don’t want it.
Given everything he’s been through, Bobby Wiseman says he should have been dead instead of…
STAT+: U.K. lawmakers urge Pfizer not to raise the price of its Covid-19 vaccine
Several U.K. lawmakers have asked Pfizer not to raise the price of its Covid-19 vaccine,…
STAT+: Pharma wins a key round in a court battle with hospitals over a drug discount program
In a victory for the pharmaceutical industry, a federal appeals court ruled drug companies have…
STAT+: FDA names former Oracle executive as new digital health leader
The Food and Drug Administration has installed Troy Tazbaz, most recently a senior vice president…
STAT+: Pharmalittle: Pfizer is scolded by U.K. industry group over CEO’s remarks on vaccination; Amgen to lay off 300 U.S. employees
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
WHO extends public health emergency over Covid but signals end could come soon
The World Health Organization announced Monday that the Covid-19 pandemic remains a public health emergency,…
STAT+: ‘A classic case’: A legal expert on why lawsuits challenging abortion pill restrictions may succeed
A pair of lawsuits was filed last week challenging restrictions on access to abortion pills…
Opinion: As it turns 40, the Orphan Drug Act for rare diseases needs a refresh
This month marks the 40th anniversary of the Orphan Drug Act. Since it was signed…